Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence - Yesilöz, Ü; Kirches, E; Hartmann, C (Neuro-oncol, 2017)
, et al.